Business
Press Release Dec 23 2025
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP,30 mg/30 mL (1 mg/mL) Multiple-Dose Vial".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 23, 2025, titled \"Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP,30 mg/30 mL (1 mg/mL) Multiple-Dose Vial\". View Attachment","length":380,"tagName":"div"}]